Pina M Cardarelli Selected Research

ulocuplumab

1/2016	Ulocuplumab (BMS-936564 / MDX1338): a fully human anti-CXCR4 antibody induces cell death in chronic lymphocytic leukemia mediated through a reactive oxygen species-dependent pathway.
1/2013	BMS-936564/MDX-1338: a fully human anti-CXCR4 antibody induces apoptosis in vitro and shows antitumor activity in vivo in hematologic malignancies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pina M Cardarelli Research Topics

Disease

8	Neoplasms (Cancer) 10/2018 - 09/2003
2	Leukemia 01/2016 - 09/2003
2	Inflammation (Inflammations) 01/2016 - 06/2002
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2013 - 03/2002
2	B-Cell Lymphoma (Lymphoma, B Cell) 02/2010 - 09/2003
2	Autoimmune Diseases (Autoimmune Disease) 02/2004 - 06/2002
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2018
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2016
1	Hematologic Neoplasms (Hematological Malignancy) 01/2016
1	Melanoma (Melanoma, Malignant) 01/2016
1	Lymphoid Leukemia 01/2013
1	Multiple Myeloma 01/2013
1	Rheumatoid Arthritis 06/2012
1	Lymphoma (Lymphomas) 05/2009
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 02/2004
1	Carcinoma (Carcinomatosis) 09/2003

Drug/Important Bio-Agent (IBA)

4	Monoclonal AntibodiesIBA 01/2016 - 03/2002
2	AntigensIBA 10/2018 - 07/2014
2	ulocuplumabIBA 01/2016 - 01/2013
2	IpilimumabIBA 01/2016 - 01/2016
2	NivolumabIBA 01/2016 - 01/2016
1	GangliosidesIBA 10/2018
1	Cisplatin (Platino)FDA LinkGeneric 10/2018
1	Complement System Proteins (Complement)IBA 10/2018
1	Etoposide (VP 16)FDA LinkGeneric 10/2018
1	Immunoglobulin G (IgG)IBA 10/2018
1	LigandsIBA 01/2016
1	Biological ProductsIBA 01/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2016
1	CXCR4 Receptors (CXCR4 Receptor)IBA 01/2016
1	CXC ChemokinesIBA 01/2016
1	CytokinesIBA 01/2016
1	Immunoconjugates (Immunoconjugate)IBA 07/2014
1	InterferonsIBA 06/2012
1	Methotrexate (Mexate)FDA LinkGeneric 06/2012
1	ChemokinesIBA 06/2012
1	Proteins (Proteins, Gene)FDA Link 06/2012
1	MDX-1100IBA 06/2012
1	MDX-1342 antibodyIBA 02/2010
1	MDX-1401IBA 05/2009
1	N- (succinyl- beta- alanyl- L- leucyl- L- alanyl- L- leucyl)doxorubicinIBA 09/2003
1	ProdrugsIBA 09/2003
1	Metalloproteases (Metalloproteinases)IBA 09/2003
1	Peptides (Polypeptides)IBA 09/2003
1	Peptide Hydrolases (Proteases)FDA Link 09/2003
1	EnzymesIBA 09/2003
1	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2003
1	IntegrinsIBA 06/2002
1	Membrane Proteins (Integral Membrane Proteins)IBA 03/2002

Therapy/Procedure

6	Therapeutics 01/2016 - 03/2002
3	Immunotherapy 01/2016 - 02/2004